Technology Commercialization Office

Showing 3 result(s) for "Animal Models"

Research tool; in-vivo transgenic mouse model with liver oncogenicity of microRNA-221.

Novel in-vivo mice models facilitating the study of pancreatic beta cell loss and corresponding type one diabetes as well as other pancreatic diseases.

The use of sarcolipin (SLN) as a novel target to increase metabolism and treat obesity.